Sinovac Covid-19 vaccine appears safe, triggers antibodies in trial in children: Researcher
The preliminary data was from Phase I and II clinical trials involving over 500 people.Reuters Sinovac Biotech's Covid-19 vaccine appears to be safe and able to trigger immune responses among children and adolescents, according to preliminary results from early and mid-stage trials, the company said late on Monday (March 22). The preliminary data was from Phase I...